APA (7th ed.) Citation

Li, L., Yang, S., Fang, F., Tian, L., He, Y., Li, J., . . . Dong, D. Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Lu, Shilei Yang, Fengqi Fang, Li Tian, Ying He, Jia Li, Yanwei Chen, and Deshi Dong. Corrigendum: The Value of Second-line Anti-HER2 Therapy in Metastatic HER-2 Positive Patients: A Cost-effectiveness Analysis in China. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Lu, et al. Corrigendum: The Value of Second-line Anti-HER2 Therapy in Metastatic HER-2 Positive Patients: A Cost-effectiveness Analysis in China. Frontiers Media S.A.